Faculty of Medical Sciences

Commercialisation

Overview

The University has a number of Intellectual Property (IP) and Commercialisation specialists who have a wide range of technical, commercial, marketing, business, corporate finance, management and legal skills.

In today’s knowledge-based economy it is widely recognised that research, innovation and entrepreneurship are crucial driving factors for the University’s, the North East’s and the UK’s long-term efficiency, competitiveness and economic growth.

Increasingly, the UK Government has an expectation for academic research to be more aligned with industrial requirements and to generate a return on public funded investment.

It's also recognised that many medical technologies (be they new medical devices, diagnostics or therapeutics) will only ever make it to the market and deliver patient benefits/cost savings through appropriate protection, diligent management and effective commercialisation.

The in the Medical School has the role of assisting University researchers to:

  • identify their intellectual discoveries
  • protect and support the development of these early-stage technologies
  • commercialise these assets through licensing deals with existing companies or by establishing spin-out companies

Technologies for Licencing

We have a range of technologies where IP is available to licence for interested companies.

Disease Modifying Osteoarthritis Therapeutic Compounds
Identification of a hit compound in clear IP space which inhibits the serine protease enzyme matriptase; a novel initiator of cartilage matrix degradation in osteoarthritis.

Egg Collection Technology (IVF)
A device that provides an enclosed system for egg collection.

Enzymatic Dispersal of Biofilms by NucB
NucB is a small, highly stable enzyme which is very active against a wide range of both bacterial and yeast biofilms. Since biofilms are a ubiquitous problem, NucB has the potential for application against a vast range of biofilm problems in the home, in industry, in personal care and in medical applications.

Engineered Biomimetic Material – Cell Adhesion/Differentiation
A synthetic protein polymer which can create a range of biomimetic materials. These include surface coatings, hydrogels and tissue scaffolds. Based upon an inert and robust bacterial protein it is simple and economic to manufacture.

Intelligent Blood Pressure Quality Display
Intelligent blood pressure measurement technology to improve the accuracy of blood pressure measurements. Inclusion of the intelligent technology in the blood pressure measurement process provides the operator with an index of quality for the blood pressure reading.

Physiologically Relevant Model of Gastrointestinal Digestion and Absorption
A novel, integrated, in vitro model gut system (MGS) which simulates the digestive and absorptive processes of the gastrointestinal (GI) tract from mouth to terminal small intestine - something which has previously been described as the 'holy grail' of research into oral delivery.

Synthetic Retina
A method of generating laminated neural retinae reminiscent of the developing human retina.

Multi-electrode Electromyography Device for Imaging Skeletal Muscle
A multi-electrode needle capable of recording skeletal muscle electrical activity from multiple sensing positions simultaneously from a single needle location site.

Asteroid: Binocular Vision Testing Device for Children
A fun, game-based stereoacuity test hosted on a 3D tablet where stereoacuity is measured as the child plays an interactive game with the viewing distance being automatically measured in real time.

Cell Culture Bioreactor for Ex Vivo Testing of Therapeutic Agents
A dynamic cell culture system which allows ex vivo tissue slices to be cultured providing a more accurate model of human disease on which to test efficacy and toxicity of candidate drug molecules.

FibroFind - Preclinical Testing Service for Anti-fibrotic Therapeutics
A large variety of reproducible optimised techniques allowing a bespoke testing programme to be developed for each client’s exact needs depending on the type of fibrotic disease, target organ(s) and any other factors involved.

Improved Blood Pressure Management System
Technology that relates to a BP management system capable of measuring actual blood pressure by detecting high frequency micro-pulses existing between systole and diastole associated with the opening and closing of an artery.

Method for Destabilising, Altering and Dispersing Biofilms - L-Arginine
A treatment comprising L-arginine which enhances biofilm removal and sensitivity to environmental or co-applied treatments, e.g. antimicrobials.

Method for Inducing Bacterial Cell Membrane Synthesis
A method of inducing cell wall-less (L-) forms of bacteria that are a suitable chassis for the commercial production of target molecules.

Spin-out Companies

We have created a number of successful spin-out companies over the past 20 years based on the novel discoveries of our researchers and the support of the Faculty's Enterprise Team.

Some of the recent spin-out companies to be created within the Medical/Life Science/Healthcare sector are:

Incubator Space

We run two laboratory incubator facilities for early-stage bio-technology and life sciences companies, and one office-based incubator embedded with the Newcastle University Institute for Ageing.

Our incubator facilities are designed to allow commercial organisations to interact closely with university academics, providing access (at commercial rates) to specialist facilities, whilst maintaining a clear separation from university labs.

The incubator facilities come equipped with basic laboratory and/or office space and shared communal spaces (such as kitchen and networking space). Whilst many of the tenants are University spin-outs - primarily from the Faculty of Medical Sciences - we also welcome tenants with no previous relationship with the University.

Medical School Bioincubator

The labs in the William Leech Building (at the main Medical School) are designed for smaller, earlier-stage companies, with most companies being two to five staff in size.

Centre for Life Bioincubator

Those provided in University space at the International Centre for Life are slightly larger and are more likely to be used by slightly more mature companies (although this differentiation is not rigidly enforced).

Business Innovation Facility

The Business Innovation Facility (based at the Campus for Ageing and Vitality) offers purpose-built offices of varying size, along with communal networking, meeting and kitchen spaces. This space is designed for companies who want to work with us within the emerging market created by an ageing society.

Newcastle Laboratories

It is anticipated that the University's lab-based incubators will close in Spring 2018. This is to coincide with the opening of Newcastle Laboratory, a purpose-built commercial laboratory facility on the Science Central Site, which is being funding by Newcastle City Council, the North East LEP's Local Growth Fund, and European Structural and Investment Funds.

Further information

Enquiries regarding University incubator space should be directed to:

Ruth Pollard
Email: ruth.pollard@newcastle.ac.uk
Telephone: +44 (0) 191 208 3583

Contact

Contact details for our Enterprise Team.

You can contact us at: 

Or if you are not sure that FMS is the right faculty for your query, then please contact:

 

You can also find individual staff profiles and contact details on the Enterprise Team contact page.